The Kenya National Drug Policy: 5. REGULATORY CONTROL: 5.5. Clinical Trials

Page d'accueil | Aide | Effacer

Anglais | Français

Etendre sommaire

Document complet

Dérouler chapitre

Préférences

Version HTML imprimable

Exporter le document en format HTML Aide

Abréviations


The Kenya National Drug Policy (WHO; 1994; 27 pages)
	FOREWORD
	ABBREVIATIONS
	1. GOAL AND OBJECTIVES OF THE NATIONAL DRUG POLICY
		1.1. The Goal of the National Drug Policy
		1.2. Specific objectives of the NDP
	2. PUBLIC SECTOR DRUG SUPPLY
		2.1. Essential Drugs List
		2.2. Essential Medical Supplies and Appliances
		2.3. Financing
		2.4. Procurement
		2.5. Distribution
	3. DRUG SUPPLY BY THE PRIVATE SECTOR & NON-GOVERNMENTAL ORGANISATIONS
		3.1. Adoption of the Essential Drugs Concept
		3.2. Generic Labelling
		3.3. Institutional and Retail Pharmacy Services
		3.4. Prescribing and Dispensing
		3.5. Drug Donations
		3.6. Financing and Pricing of Drugs in the Private and NGO Sectors
	4. VETERINARY DRUG SUPPLY
		4.1. Selection and Supply of Veterinary Drug
		4.2. Financing
	5. REGULATORY CONTROL
		5.1. Drug Control and Administration
		5.2. Drug Registration
		5.3. Scheduling of Drugs
		5.4. Pharmaceutical Inspectorate
		5.5. Clinical Trials
		5.6. Traditional Medicine
		5.7. Professional Associations and Professional Ethics
	6. RATIONAL DRUG USE
		6.1. Prescription Practices
		6.2. Treatment Guidelines
		6.3. Generic Prescribing
		6.4. Education and Training
		6.5. Pharmacy and Therapeutic Committees
		6.6. Drug Information
		6.7. Drug Advertising and Promotion
	7. QUALITY ASSURANCE
		7.1. National Quality Control Laboratory
		7.2. Good Manufacturing Practices
		7.3. Certification Schemes on the Quality of Pharmaceuticals
	8. DRUG ABUSE
	9. IMPORTATION AND EXPORTATION OF DRUGS
		9.1. Importation of Drugs
		9.2. Exportation of Drugs
	10. LOCAL PRODUCTION
		10.1. Local Manufacture
		10.2. Patents
		10.3. Research and Development
	11. MANPOWER TRAINING AND DEVELOPMENT
	12. LEGISLATION
	13. MONITORING & EVALUATION
	14. INTERSECTORAL AND TECHNICAL COOPERATION

5.5. Clinical Trials

Clinical trials are an essential part of drug development. The Pharmacy and Poisons Board will approve protocols for clinical trials for new drugs and established guidelines for clinical trials involving drugs already registered in Kenya.

S'il vous plaît envoyez vos commentaires

Abréviations

Anglais | Français